Literature DB >> 1551692

The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes.

E M Kniep1, I Strelow, M L Lohmann-Matthes.   

Abstract

Stimulation with lipopolysaccharide (LPS) initiated monocytes to produce interleukin-2 receptor light chain (p55 IL-2R). After stimulation with LPS for 48 hr, considerable quantities of soluble IL-2R were found in the supernatants of monocytes, exceeding even the amount of soluble IL-2R produced by activated T lymphocytes. Cell-associated p55 IL-2R was also increased during the first 24 hr of stimulation, after which time it remained constant. Fractionation of cells and analysis of cytoplasm, mitochondria, plasma membranes and nuclei for the presence of p55 IL-2R revealed that the main portion of receptor was present in the cytoplasm. This led to the conclusion that in monocytes cell-associated p55 IL-2R is not necessarily attached to membranes but is present in a soluble form in the cytoplasm, presumably freshly produced with the aim of being secreted. Stimulation of monocytes with pure recombinant interferon-gamma did not lead to augmentation of p55 IL-2R, as shown by enzyme-linked immunosorbent assay, binding of antibodies directed against the receptor (anti-Tac, CD25) and analysis of p55 IL-2R gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551692      PMCID: PMC1384710     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 3.  The multi-subunit interleukin-2 receptor.

Authors:  T A Waldmann
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes.

Authors:  W Holter; C K Goldman; L Casabo; D L Nelson; W C Greene; T A Waldmann
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

5.  Interferon-gamma induces expression of the interleukin 2 receptor gene in human monocytes.

Authors:  A Rambaldi; D C Young; F Herrmann; S A Cannistra; J D Griffin
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

6.  IL-2 enhances c-fms expression in human monocytes.

Authors:  I Espinoza-Delgado; D L Longo; G L Gusella; L Varesio
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

7.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.

Authors:  W J Leonard; J M Depper; G R Crabtree; S Rudikoff; J Pumphrey; R J Robb; M Krönke; P B Svetlik; N J Peffer; T A Waldmann
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

8.  Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2.

Authors:  F Herrmann; S A Cannistra; A Lindemann; D Blohm; A Rambaldi; R H Mertelsmann; J D Griffin
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

9.  Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.

Authors:  E S Kleinerman; K L Erickson; A J Schroit; W E Fogler; I J Fidler
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  11 in total

1.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 2.  Daclizumab therapy for multiple sclerosis.

Authors:  Bibiana Bielekova
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

3.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

4.  Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.

Authors:  Calliope A Dendrou; Vincent Plagnol; Erik Fung; Jennie H M Yang; Kate Downes; Jason D Cooper; Sarah Nutland; Gillian Coleman; Matthew Himsworth; Matthew Hardy; Oliver Burren; Barry Healy; Neil M Walker; Kerstin Koch; Willem H Ouwehand; John R Bradley; Nicholas J Wareham; John A Todd; Linda S Wicker
Journal:  Nat Genet       Date:  2009-08-23       Impact factor: 38.330

5.  Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.

Authors:  Lisa M Maier; David E Anderson; Christopher A Severson; Clare Baecher-Allan; Brian Healy; David V Liu; K Dane Wittrup; Philip L De Jager; David A Hafler
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

6.  The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region.

Authors:  Marina A Afanasyeva; Lidia V Putlyaeva; Denis E Demin; Ivan V Kulakovskiy; Ilya E Vorontsov; Marina V Fridman; Vsevolod J Makeev; Dmitry V Kuprash; Anton M Schwartz
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

7.  Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

Authors:  A Martens; R A Janssen; D T Sleijfer; A A Heijn; N H Mulder; T H The; L de Leij
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

8.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

9.  CpG methylation changes within the IL2RA promoter in type 1 diabetes of childhood onset.

Authors:  Marie-Pierre Belot; Delphine Fradin; Nga Mai; Sophie Le Fur; Diana Zélénika; Julie Kerr-Conte; François Pattou; Bruno Lucas; Pierre Bougnères
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

10.  Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.

Authors:  Kate Downes; M Loredana Marcovecchio; Pamela Clarke; Jason D Cooper; Ricardo C Ferreira; Joanna M M Howson; Jennifer Jolley; Sarah Nutland; Helen E Stevens; Neil M Walker; Chris Wallace; David B Dunger; John A Todd
Journal:  Diabetologia       Date:  2013-11-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.